Literature DB >> 728459

Binding of thrombin to human platelet plasma membranes.

S W Tam, T C Detwiler.   

Abstract

Binding of 125I-labeled thrombin to isolated human platelet plasma membranes was studied. Two classes of sites, one with high and one with low affinity for thrombin, were demonstrated. The apparent dissociation constants for the high and low affinity sites were 3.2 and 600 nM, respectively, similar to values obtained with intact platelets. Maximum binding was within 10 s, the shortest time measured, and then decreased with time to a constant level of binding within 45 s. When the equilibrium was perturbed by dilution, the system re-equilibrated with less thrombin bound than in a control that was dilute before mixing thrombin and membranes. Neither the time-dependent decrease nor the dilution effect were observed with phenylmethylsulfonyl-125I-labelled thrombin, an irreversibly inhibited thrombin, suggesting that these phenomena may involve a thrombin-catalyzed modification of the membranes leading decreased binding.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728459     DOI: 10.1016/0304-4165(78)90064-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Thrombin-induced calcium-independent degranulation of human neutrophils.

Authors:  D Baranes; J Matzner; E Razin
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

2.  Anion channel blockers cause apparent inhibition of exocytosis by reacting with agonist or secretory product, not with cell.

Authors:  J G Vostal; D M Reid; C E Jones; N R Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Thrombin-induced phosphoinositide hydrolysis in platelets. Receptor occupancy and desensitization.

Authors:  E M Huang; T C Detwiler
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

4.  Hirudin: Its Biology and Clinical Use.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.